Breaking News Instant updates and real-time market news.

WMT

Walmart

$101.58

-1.37 (-1.33%)

, JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

20:25
11/14/18
11/14
20:25
11/14/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Walmart (WMT), consensus $1.01... J.C. Penney (JCP), consensus (56c)... Berry Global (BERY), consensus 87c.

WMT

Walmart

$101.58

-1.37 (-1.33%)

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

BERY

Berry Global

$45.91

-0.49 (-1.06%)

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

WMT Walmart
$101.58

-1.37 (-1.33%)

11/08/18
BARD
11/08/18
NO CHANGE
Target $110
BARD
Outperform
Walmart headed for 'solid Q3 results' says Baird
Baird analyst Peter Benedict kept his Outperform rating and $110 price target on Walmart ahead of its Q3 results, saying he has an upward bias to its U.S. comps expectations after the management's "bullish" tone at last month's investor meeting. The analyst adds that the prospects for sustained momentum also appear to be good given the "multiple in-store and online initiatives converging" and the backdrop for consumer spending remaining firm.
11/02/18
SPHN
11/02/18
DOWNGRADE
Target $26
SPHN
Underweight
Synchrony downgraded to Underweight from Equal Weight at Stephens
Stephens analyst Vincent Caintic downgraded Synchrony (SYF) to Underweight from Equal Weight, citing the negative implications he sees from the lawsuit against the company from Walmart (WMT). Beyond the potential for over $800M in damages, the suit implies the Sam's Club account is lost, the Amazon (AMZN) account is "in jeopardy," and other retailers can be expected to "take a hard look" at their own relationships with Synchrony, Caintic believes. He lowered his price target on Synchrony shares to $26 from $32.
10/29/18
COWN
10/29/18
NO CHANGE
Target $120
COWN
Walmart price target raised to $120 from $115 at Cowen
Cowen analyst Oliver Chen raised his price target on Walmart to $120 from $115 following his meeting with management. The analyst said the company is well positioned in the retail race, citing its rapid acquisition of new brands combined with increasing same-day deliveries and a fresh food supply chain. Chen reiterated his Outperform rating on Walmart shares.
10/22/18
MKMP
10/22/18
NO CHANGE
Target $105
MKMP
Neutral
Walmart price target lowered to $105 at MKM Partners after analyst meeting
MKM Partners analyst Patrick McKeever nudged his price target on Walmart lower to $105 from $107 and also kept his Neutral rating after its annual meeting with the investment community, saying he has turned "more positive" on the outlook for the company's top line. The analyst cites Walmart's continued benefits coming from a "very favorable consumer backdrop, better store execution driven by wage/training investments, aggressive adaption of new technology, an improved fresh assortment, and strong momentum in e-commerce." McKeever anticipates more challenges for Walmart's profitability however because of wider e-commerce losses than anticipated in addition to incremental pressures coming from the fuel/transport costs and retail price investment.
JCP J.C. Penney
$1.23

-0.05 (-3.91%)

08/16/18
FBCO
08/16/18
NO CHANGE
Target $1
FBCO
J.C. Penney price target cut to $1 from $2 at Credit Suisse
08/17/18
SBSH
08/17/18
NO CHANGE
Target $0.5
SBSH
Sell
J.C. Penney price target lowered to 50c from $2 at Citi
Citi analyst Paul Lejuez said that J.C. Penney " finds itself in a very difficult position" following its Q2 report given that they lack a CEO and head merchant and are struggling at a time when peers are seeing improvement in their business. While he does not see near-term liquidity issues, Lejuez said there is not that much equity value given the company's high debt load. He lowered his price target on J.C. Penney shares to 50c from $2 and keeps a Sell rating on the stock.
10/03/18
PIPR
10/03/18
NO CHANGE
Target $1.5
PIPR
Neutral
Piper Jaffray keeps Neutral on J.C. Penney after CEO announcement
Piper Jaffray analyst Erinn Murphy maintains a Neutral rating on J.C. Penney with a $1.50 price target after Jill Soltau was named the company's new CEO. Soltau has direct insights on Penny's core consumer given the overlap of the consumer base in her prior roles, Murphy tells investors in a research note. The analyst, however, remains sidelined with respect to the shares given her longer-term view on department store retailing and her belief that inventory at Penny "is still in process of being right-sized."
10/12/18
MSCO
10/12/18
NO CHANGE
Target $1.5
MSCO
Equal Weight
Morgan Stanley sees near-term pressure, long-term gain for Penney if Sears folds
Amid recent headlines regarding Sears (SHLD) adding a restructuring expert and reportedly pursuing a bankruptcy filing, Morgan Stanley analyst Kimberly Greenberger noted that she believes J.C. Penney (JCP) had the highest store overlap with Sears, K-Mart, and Sears Specialty Stores within both a quarter mile and half mile radius. If Sears closes additional stores or engages in liquidation sales, retailers in the close trade areas could experience some short-term pressure, said Greenberger, who added that Sears has already been closing stores for years. In the medium to long-term, she expects J.C. Penney and other retailers in the respective trade areas to potentially benefit from these closures. Greenberger, who views Penney's near-term debt maturities as "manageable," keeps an Equal Weight rating and $1.50 price target on the shares.
BERY Berry Global
$45.91

-0.49 (-1.06%)

08/15/18
RBCM
08/15/18
UPGRADE
Target $54
RBCM
Sector Perform
Bemis upgraded to Sector Perform at RBC Capital on expected Amcor deal approval
As reported earlier, RBC Capital analyst Arun Viswanathan upgraded Bemis to Sector Perform from Underperform and raised his price target to $54 from $44, saying that while he is cautious about the company's food packaging business, he expects the previously announced acquisition by Amcor to be approved by all parties with minimal divestitures. The analyst further states that the two companies are highly complementary and the combination should yield about $180M in synergies. Viswanathan also likes Berry Global (BERY) and Graphic Packaging Holding (GPK) based on their attractive valuation.
08/07/18
UBSW
08/07/18
DOWNGRADE
Target $54
UBSW
Neutral
Bemis downgraded to Neutral from Buy at UBS
UBS analyst Edlain Rodriguez downgraded Bemis (BMS) to Neutral following Amcor's offer to acquire the company. The analyst raised his price target for the shares to $54 from $52, which reflects a 50/50 blend of his standalone Bemis target of $52 and the implied current deal price of $55. Rodriguez says the closest plastic packaging peers to Bemis are Sealed Air (SEE), Berry Global (BERY) and Sonoco Products (SON).
05/18/18
JEFF
05/18/18
INITIATION
Target $67
JEFF
Buy
Berry Global initiated with a Buy at Jefferies
Jefferies analyst Daniel Rizzo started Berry Global Group with a Buy rating and $67 price target. The company has one of the highest free cash flow profiles in Packaging, and deleveraging returning cash should drive a multiple expansion, Rizzo tells investors in a research note.
05/04/18
BARD
05/04/18
NO CHANGE
Target $65
BARD
Outperform
Berry Global shares appear oversold, says Baird
Baird analyst Ghansham Panjabi said weak volumes and an unfavorable cost/spread continue to weigh on Berry Global shares, but at this point the shares appear oversold. The analyst believes its free cash flow and volume outlook are move favorable and he sees pricing pressures easing over the next 2-3 quarters. Panjabi reiterated his Outperform rating and lowered his price target to $65 from $70 on Berry Global shares.

TODAY'S FREE FLY STORIES

ATTO

Atento

$3.95

0.06 (1.54%)

20:51
03/19/19
03/19
20:51
03/19/19
20:51
Earnings
Atento reports Q4 recurring EPS 21c, consensus 17c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

TRHC

Tabula Rasa HealthCare

$60.28

1.35 (2.29%)

20:47
03/19/19
03/19
20:47
03/19/19
20:47
Recommendations
Tabula Rasa HealthCare analyst commentary at Piper Jaffray »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

GIS

General Mills

$47.24

-0.365 (-0.77%)

20:25
03/19/19
03/19
20:25
03/19/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

TRN

Trinity Industries

$22.46

-0.25 (-1.10%)

20:20
03/19/19
03/19
20:20
03/19/19
20:20
Hot Stocks
Trinity Industries names Leldon Echols chairman of the board »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

TIGR

UP Fintech

$0.00

(0.00%)

20:06
03/19/19
03/19
20:06
03/19/19
20:06
Syndicate
UP Fintech 13M share IPO priced at $8.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

SND

Smart Sand

$4.27

-0.4 (-8.57%)

20:01
03/19/19
03/19
20:01
03/19/19
20:01
Initiation
Smart Sand initiated at B. Riley FBR »

Smart Sand initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$0.00

(0.00%)

20:00
03/19/19
03/19
20:00
03/19/19
20:00
Initiation
Lyft initiated at DA Davidson »

Lyft initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

DERM

Dermira

$14.13

1.52 (12.05%)

19:40
03/19/19
03/19
19:40
03/19/19
19:40
Syndicate
Dermira 9.8M share Secondary priced at $13.25 per share »

Citi, Cowen, Cantor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

19:38
03/19/19
03/19
19:38
03/19/19
19:38
Upgrade
Nevro rating change at BMO Capital »

Nevro upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

TORC

ResTORbio

$7.16

-1.81 (-20.18%)

19:34
03/19/19
03/19
19:34
03/19/19
19:34
Syndicate
ResTORbio 7.2M share Secondary priced at $6.95 »

BofA/Merrill, SVB Leerink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

19:33
03/19/19
03/19
19:33
03/19/19
19:33
Upgrade
Nevro rating change at BMO Capital »

Nevro upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

PFE

Pfizer

$42.32

0.51 (1.22%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

19:17
03/19/19
03/19
19:17
03/19/19
19:17
Hot Stocks
Pfizer, Merck KGaA discontinue Phase III JAVELIN Ovarian PARP study »

Merck KGaA (MKGAY) and…

PFE

Pfizer

$42.32

0.51 (1.22%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 30

    Apr

  • 18

    May

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

, GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

19:11
03/19/19
03/19
19:11
03/19/19
19:11
Hot Stocks
Google outlines changes to Android mobile options, ad formats in Europe »

Google said in a blog…

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

, GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

19:08
03/19/19
03/19
19:08
03/19/19
19:08
Periodicals
Google offers Android, product ad concessions for Europe, WSJ says »

Google intends to ask all…

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

, SCS

Steelcase

$17.49

-0.115 (-0.65%)

19:06
03/19/19
03/19
19:06
03/19/19
19:06
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

SCS

Steelcase

$17.49

-0.115 (-0.65%)

AUPH

Aurinia Pharmaceuticals

$6.40

0.13 (2.07%)

NVRO

Nevro

$44.76

0.37 (0.83%)

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

TME

Tencent Music

$18.65

-0.48 (-2.51%)

WPRT

Westport

$1.50

(0.00%)

AIR

AAR Corp.

$35.10

(0.00%)

FDX

FedEx

$181.50

-0.92 (-0.50%)

FNV

Franco-Nevada

$75.64

0.035 (0.05%)

PRNB

Principia Biopharma

$36.88

0.48 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 01

    Apr

  • 02

    Apr

  • 05

    Apr

  • 14

    May

  • 28

    May

  • 24

    Jun

  • 26

    Jun

LGIH

LGI Homes

$54.89

-2.27 (-3.97%)

19:02
03/19/19
03/19
19:02
03/19/19
19:02
Hot Stocks
LGI Homes announces new community in Las Vegas »

LGI Homes, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

19:01
03/19/19
03/19
19:01
03/19/19
19:01
Hot Stocks
Sage says Zulresso approval represents 'game-changing approach' to PPD »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

QTRX

Quanterix

$24.59

-0.01 (-0.04%)

18:55
03/19/19
03/19
18:55
03/19/19
18:55
Syndicate
Breaking Syndicate news story on Quanterix »

Quanterix files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIHS

Senmiao Technology

$4.71

-0.275 (-5.52%)

18:55
03/19/19
03/19
18:55
03/19/19
18:55
Syndicate
Breaking Syndicate news story on Senmiao Technology »

Senmiao Technology files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

18:54
03/19/19
03/19
18:54
03/19/19
18:54
Syndicate
Breaking Syndicate news story on Invitation Homes »

Invitation Homes files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

PULM

Pulmatrix

$1.70

-0.09 (-5.03%)

18:53
03/19/19
03/19
18:53
03/19/19
18:53
Syndicate
Breaking Syndicate news story on Pulmatrix »

Pulmatrix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SIEN

Sientra

$8.81

-0.4 (-4.34%)

18:51
03/19/19
03/19
18:51
03/19/19
18:51
Recommendations
Sientra analyst commentary at Wells Fargo »

Sientra implied costs to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

18:50
03/19/19
03/19
18:50
03/19/19
18:50
Syndicate
Breaking Syndicate news story on Invitation Homes »

Invitation Homes files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

FDX

FedEx

$181.50

-0.92 (-0.50%)

18:45
03/19/19
03/19
18:45
03/19/19
18:45
Hot Stocks
FedEx CEO: Domestic business is pretty good »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

LYFT

Lyft

$0.00

(0.00%)

18:41
03/19/19
03/19
18:41
03/19/19
18:41
Periodicals
Lyft IPO oversubscribed so far, Reuters reports »

Lyft's IPO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.